Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
Rapid

Blue-toe and cholesterol embolisation syndromes

Essential points for quick revision.

Saved on this device
!
Digital ischaemia with preserved pulses

A painful blue or purple toe may reflect repeated microembolisation from an unstable proximal plaque or aneurysm even when pedal pulses remain palpable.

Action: Obtain urgent vascular assessment, document toe and whole-limb viability, start source-directed imaging without delaying threatened-limb care, and escalate immediately for spreading ischaemia, neurological loss, sepsis or multiorgan cholesterol embolisation.

Synopsis

Recognise blue-toe ischaemia, distinguish thromboembolic occlusion from cholesterol crystal showering and direct urgent source-focused multidisciplinary care.

  • Blue-toe syndrome describes painful blue or violaceous digits from small-vessel occlusion; palpable pedal pulses do not exclude it because proximal large arteries may remain patent.
  • Thromboembolic blue toe is often abrupt and source-related, whereas cholesterol crystal embolisation may evolve subacutely with livedo, kidney injury and inflammatory laboratory features.
  • Ask about recent angiography, vascular surgery and anticoagulant or thrombolytic exposure, while remembering that cholesterol embolisation can also occur spontaneously.

Key red flags

Rapidly spreading digital cyanosis, rest pain, sensory or motor loss, or fixed tissue change indicates threatened tissue and needs immediate vascular review.

Blue toes with livedo reticularis, rising creatinine, eosinophilia or systemic symptoms after angiography suggests cholesterol crystal embolisation affecting multiple organs.

Fever, murmur, positive blood cultures or retinal and neurological emboli raises infective endocarditis and requires urgent sepsis and cardiac assessment.

Painful blue digit

Sudden blue or violaceous toe with pain, coolness or tenderness indicates digital ischaemia and warrants urgent vascular assessment.

Pulses may remain

Palpable dorsalis pedis or posterior tibial pulses are compatible with distal microembolisation and must not be used to dismiss blue-toe syndrome.

Cholesterol shower pattern

Blue toes or livedo with subacute renal decline, constitutional symptoms and eosinophilia after arterial instrumentation suggests multisystem cholesterol embolisation.

Thromboembolic pattern

Abrupt focal ischaemia after loss of a graft, aneurysm thrombosis or cardiac embolic event favours platelet-fibrin or thrombus material.

Infective source clues

Fever, new murmur, splinter haemorrhages or positive cultures with digital lesions requires urgent assessment for infective endocarditis.

Investigation priorities

01
Full vascular and digital examinationFirst step

Define tissue viability and distinguish distal embolisation from whole-limb acute ischaemia.

Management branches

Worked caseClassify a blue painful toe

A patient develops a painful purple toe with palpable pedal pulses two weeks after coronary angiography and creatinine is rising.

  1. Inputs: document timing, procedure route, skin distribution, whole-limb viability, pulses and Doppler, renal trajectory, urine, eosinophils, inflammatory markers and medicines.
  2. Reasoning: preserved pulses localise disease distally, while delayed renal decline plus cutaneous emboli after arterial instrumentation makes cholesterol crystal showering more likely than one large thrombus.

Key medicines

Antiplatelet therapyFor atherosclerotic peripheral arterial disease, prescribe the locally selected single antiplatelet agent at its licensed dose, commonly clopidogrel 75 mg orally once daily, unless source or procedure requires another regimen.Check active bleeding, platelet count, interactions and planned biopsy or surgery. Do not present antiplatelet treatment as a proven reversal of cholesterol embolisation; duration and combinations depend on the vascular intervention and wider cardiovascular indication.
High-intensity statinUse a high-intensity statin for established atherosclerotic disease, commonly atorvastatin 80 mg orally once daily, reducing or selecting an alternative for interactions, intolerance or specialist renal guidance.Check liver disease, interacting medicines and muscle symptoms; severe renal dysfunction and frailty may alter selection. A statin supports secondary prevention but is not an acute antidote to lodged cholesterol crystals.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 12 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 12 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom